INTRODUCTION
============

Ischemic injury results from the interruption of blood flow and causes damage to active tissues; ischemic reperfusion injury (IRI) occurs after the restoration of blood flow, leading to additional tissue injury [@b1-cln_70p61]. In 1986, Parks and Granger [@b2-cln_70p61] reported that reperfusion is more harmful than ischemia alone. In particular, the tissue damage that is caused by ischemia and reperfusion in the intestine is associated with high morbidity and mortality in surgical patients. IRI occurs in cases of abdominal aortic aneurysm surgery, hemorrhagic shock, acute mesenteric ischemia (AMI), strangulated hernia, neonatal necrotizing enterocolitis, cardiopulmonary bypass and organ transplantation [@b3-cln_70p61]. Among the internal organs, the intestine is most sensitive to IRI [@b1-cln_70p61]. Intestinal IRI can lead to damage in the intestinal mucosa and the release of various inflammatory mediators, potentially resulting in the development of systemic inflammatory response syndrome (SIRS) and further leading to multiple organ failure (MOF), especially acute lung injury (ALI) [@b4-cln_70p61]-[@b7-cln_70p61]. Ischemia-reperfusion causes local and systemic changes in hemodynamics, endothelial function, microcirculation, fluid equilibrium and metabolic homeostasis while also inducing the complement and inflammatory pathways [@b8-cln_70p61]-[@b14-cln_70p61]. In an attempt to attenuate this damage, several treatment modalities have been applied in various animal models of IRI, such as hypothermia, antioxidants, ischemic preconditioning (IPC) and modulation of inflammatory mediators and adhesion molecules. Among these approaches, IPC seems to be the most promising against reperfusion injury, as it increases the bowel\'s tolerance against the damage caused by ischemia followed by reperfusion [@b15-cln_70p61]-[@b17-cln_70p61].

In 1986, Murry et al. introduced the concept of IPC as short episodes of ischemia followed by short periods of reperfusion preceding a prolonged ischemia; this approach was shown to protect organs against subsequent longer ischemia [@b18-cln_70p61]. IPC of the intestine was first described by Hotter et al. in 1996 [@b19-cln_70p61] and subsequent studies have confirmed this phenomenon. Studies in shock models show that IPC before intestinal ischemia causes a significant reduction in the inflammatory response in the lungs and intestinal injuries due to hemorrhagic shock [@b20-cln_70p61]. However, the precise mechanism by which IPC confers protection to the intestine remains unclear.

Blood is the most accessible component of the vertebrate body fluid system and has frequently been examined to assess physiological status [@b21-cln_70p61]. Hematimetric parameters have long been used as diagnostic tools for a large number of diseases, such as leukemias, anemias and infectious diseases. However, few studies have collectively addressed the prognostic values of these parameters using multivariate analysis and to our knowledge, no studies have addressed IPC. The purpose of this study was to obtain a basic knowledge of the hematological factors after IRI and IPC in rats. In this prospective study, we evaluated the significance of routine blood parameters after intestinal ischemia and preconditioning in rats, the results of which could help in the early diagnosis of IRI and in understanding how IPC affects blood components.

MATERIALS AND METHODS
=====================

Experimental subjects and sample collection
-------------------------------------------

Male Wistar rats without inflammatory disease and weighing 250--350 g were collected from the animal house of the Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo State, Brazil. The project was approved by the Ethics Committee of FMUSP (Protocol No. 8186) for the use of rats as experimental subjects. The animals were provided access to food and water ad libitum until the time of the experiment.

Experimental groups
-------------------

Forty rats were randomly allocated into the following four groups ([Figure 1](#f1-cln_70p61){ref-type="fig"}), where n represents the number of animals per group:

1- The control group (C) (n = 10), without any surgical procedure.

2- The sham laparotomy group (LAP) (n = 10), without clamping of any artery, but receiving the same surgical procedure except for the clamping.

3- Ischemia/reperfusion (IR) group (n = 10), submitted to superior mesenteric artery occlusion (SMAO) for 45 min followed by 120 min of reperfusion.

4- Ischemic preconditioning (IPC) group (n = 10), submitted to a 10-min period of SMAO followed by 10-min reperfusion immediately before 45 min of ischemia and 120 min of reperfusion, as in the IR group.

Hematological analyses
----------------------

We collected 20 µl of blood from the tails of all animals before and after surgery and injected the samples into a veterinary automated cell counter (BC-2800Vet, Shenzhen Mindray Bio-Medical Electronics Co., Nanshan, China). The analyzed hematimetric parameters included the total erythrocyte count (RBC), total white blood cell (WBC) count, hematocrit (HCT) level, hemoglobin (Hb) concentration, erythrocyte indices as mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), platelet (PLT) count, mean platelet volume (MPV), platelet distribution widths (PDW), plateletcrit (PCT) and WBC differential count [@b22-cln_70p61],[@b23-cln_70p61].

Surgical procedures
-------------------

The surgical procedures were performed in the Laboratory of Surgical Physiopathology (LIM-62), department of Surgery, FMUSP. Rats from all of the groups were anesthetized with intraperitoneal (i.p.) injections of sodium pentobarbital (45 mg/kg) and ketamine (80 mg/kg) + xylazine (7 mg/kg) and their core body temperatures were maintained at 37°C. After midline laparotomy, the superior mesenteric artery was isolated near its aortic origin. During this procedure, the intestinal tract was placed between gauze pads that had been soaked with warmed 0.9% NaCl solution. In rats from the IR group, the superior mesenteric artery was clamped, resulting in total occlusion of the artery for 45 min. After the time of occlusion, the clamps were removed and blood samples were collected from the tail after 120 min of reperfusion. In the rats of the IPC group, the ischemic procedure described above was preceded by 10 min of clamping followed by 10 min of reperfusion.

Statistical analysis
--------------------

For statistical analysis, the data were first checked for normality by applying the D′Agostino & Pearson omnibus normality test. The data were normalized and outliers were removed, based on the Thompson tau technique; then, normality was reconfirmed with the above-mentioned normality test. Variance analysis (one-way ANOVA) was used to determine the difference between the groups and the Tukey-Kramer test was used to compare and determine the means that differed significantly from each other using the Graph Pad Prism program (V.6.0c). Values with *p*\<0.05 were considered significant.

RESULTS
=======

The hematological parameters of the control, laparotomy, ischemia/reperfusion and IPC groups are summarized in [Supplementary Table 1](#t1-cln_70p61){ref-type="table"}.

All of the surgical groups (LAP, IR and IPC) showed a remarkably smaller amount of lymphocytes than did the control group. Among the surgical groups, the IR group showed a decrease in lymphocyte count (*p* = 0.0021) compared with the LAP group; however, an increase was noted in the IPC group (*p* = 0.0171) compared with IR group ([Figure 2](#f2-cln_70p61){ref-type="fig"}-A).

The WBC counts showed a significant increase in both the IR (*p* = 0.0005) and the IPC (*p* = 0.0074) groups compared with the control group ([Figure 2](#f2-cln_70p61){ref-type="fig"}-B). The elevation in WBCs was more prominent in the IR group than in the IPC group. A significant increase in the granulocyte count was observed in the LAP, IR and IPC groups compared with the controls; there was also an increase in the IR group compared with the LAP group (*p* = 0.0015), whereas the IPC group showed a significant reduction (*p* = 0.0168) compared with the IR group, almost approaching the level of the LAP group ([Figure 2](#f2-cln_70p61){ref-type="fig"}-C).

Platelets showed a significant difference between the IR and IPC groups. The PLT counts were higher (*p* = 0.0340) in the IR group than in the IPC group ([Figure 2](#f2-cln_70p61){ref-type="fig"}-D) and the MPV also showed a significantly increased value in the IR (*p* = 0.0096) and IPC (*p* = \<0.0001) groups compared with the controls. In preconditioned rats, the MPV was higher than that in LAP (*p* = 0.0004) and IR rats (*p* = 0.0485) ([Figure 2](#f2-cln_70p61){ref-type="fig"}-E). The PDW was significantly greater in IPC rats compared to all of the other groups. The *p*-values for the IPC group compared with the control, LAP and IR groups are 0.0003, 0.0015 and 0.0011, respectively ([Figure 2](#f2-cln_70p61){ref-type="fig"}-F).

The levels of monocytes, RBCs, Hb, MCV and MCH were not influenced significantly in any experimental group. The HCT level was increased (*p* = 0.0082) in the IR group compared with the control group ([Figure 1-A, supplementary](#f3-cln_70p61){ref-type="fig"}). The MCHC was decreased in the IR group (*p* = 0.0111) compared with the controls, whereas there was an increase in the MCHC value in the IPC group (*p* = 0.0111) compared with the IR group, which restored the MCHC value to a normal level ([Figure 1-B, supplementary](#f3-cln_70p61){ref-type="fig"}). The red cell deviation width was higher (*p* = 0.0152) in the IPC group than the control group, although no other group showed a significant difference ([Figure 1-C, supplementary](#f3-cln_70p61){ref-type="fig"}). Both the IR and IPC groups showed significant differences regarding their PCT levels, whereas the remaining groups did not show any significant differences. The PCT level was higher (*p* = 0.0264) in the IR group compared with the IPC group ([Figure 2](#f2-cln_70p61){ref-type="fig"}-D).

DISCUSSION
==========

IPC has been studied as a protective strategy against IRI in intestinal models [@b19-cln_70p61],[@b20-cln_70p61]. In humans, prolonged jejunal ischemia (45 min) followed by reperfusion results in intestinal barrier integrity loss, which is accompanied by a significant translocation of endotoxins. These phenomena result in an inflammatory response that is characterized by complement activation, endothelial activation, neutrophil sequestration and the release of pro-inflammatory mediators into circulation [@b24-cln_70p61]. A comparison of the effect of IR and IPC on blood parameters has not been made using the 45-min SMAO model in rats. Lymphocyte loss and dysfunction have been consistently reported in animal models of both SIRS and sepsis [@b25-cln_70p61] and preventing lymphocyte dysfunction, specifically lymphocyte apoptosis following sepsis, has been shown to improve survival after sepsis [@b26-cln_70p61]. Recently, a decrease in the lymphocyte percentage was observed following IR and local and remote IPC in a rat model with temporary supraceliac aortic clamping [@b27-cln_70p61]. IPC also prevented lymphocyte loss compared with that observed in the IR group in our study.

We observed a significant increase in the WBC count after IR. Postoperative leukocytosis represents a normal physiologic response to surgery [@b28-cln_70p61]. However, an augmentation in the WBC count has been viewed as a predictor of ischemic stroke [@b29-cln_70p61]. This increase is due to the marked elevation of leukocyte activation, as previously described in myocardial ischemia and reperfusion in dogs [@b30-cln_70p61]. The increased number of granulocytes after ischemic strokes leads to tissue damage, as these cells are implicated in the early responses of the hemostatic and inflammatory processes [@b31-cln_70p61]. Intestinal ischemia is characterized by the production of cytokines [@b32-cln_70p61] and the sequestration of polymorphonuclear neutrophils (PMNs) into the ischemically damaged tissue. The complement system also contributes to the attraction of neutrophils to ischemically damaged areas [@b33-cln_70p61], where neutrophil-released myeloperoxidase (MPO) and other proinflammatory mediators further contribute to IR-induced tissue damage [@b34-cln_70p61]. [Figure 2](#f2-cln_70p61){ref-type="fig"}-C clearly shows a significant reduction in circulating granulocytes of the IPC group compared with the IR group, suggesting a protective aspect of IPC.

With the exception of the MCHC values, our results concerning RBCs, Hb, MCV, MCH and HCT are similar to those of a study using a canine model to investigate limb IR, with or without cooling [@b35-cln_70p61]. Dehydration during surgery or fluid sequestration due to edema can result in a higher-than-normal HCT level [@b36-cln_70p61]. This increase was more prominent in the IR group and showed no significant difference in any other group. Similarly, an increase in HCT was observed in the IR compared with local IPC and remote IPC groups in a similar model using temporary supraceliac aortic clamping [@b27-cln_70p61].

Platelets also participate in ischemic strokes [@b37-cln_70p61] and IR-mediated tissue damage [@b38-cln_70p61] through the modulation of leukocyte function and the generation of free radicals and proinflammatory mediators, such as thromboxane (TxA2), leukotrienes, serotonin, platelet factor-4 and platelet-derived growth factor (PDGF) [@b39-cln_70p61],[@b40-cln_70p61]. Similar to leukocytes, the expression of P-selectin on the platelet surface contributes to rolling and firm adherence to the vascular endothelium and in the interaction with leukocytes during post-ischemic reperfusion, resulting in increased expression of adhesion molecules, the generation of superoxide and the phagocytic activity of leukocytes [@b39-cln_70p61],[@b41-cln_70p61]. The inhibition of platelet adhesion by the administration of an anti-fibrinogen antibody was shown to decrease short-term liver injury after ischemia. In addition, platelet-derived serotonin is a mediator of tissue repair after hepatic normothermic ischemia in mice [@b42-cln_70p61],[@b43-cln_70p61]. We observed a significant decrease in platelets in the IPC group compared with the IR group. However, the role of platelets in the progression of tissue damage after IR injury remains unclear. A recent study showed that platelet-deficient mice showed significant reductions in damage to their villi in response to IR compared with mice with normal platelet counts [@b44-cln_70p61].

Previous studies showed that the MPV was higher when there was destruction of platelets associated with inflammatory bowel disease [@b45-cln_70p61], whereas other studies showed that the MPV was not associated with stroke severity or functional outcomes [@b46-cln_70p61]. The activation of platelets leads to morphologic changes, including pseudopodia formation and the development of a spherical shape. Platelets with an increased number and size of pseudopodia differ in size, possibly affecting the PDW. Indeed, we found an inverse relationship between the PLT count and MPV value after IR and IPC, which suggests that IPC lowers the PLT count but increases the MPV value. However, a recent study in patients who underwent surgical intervention for acute mesenteric ischemia showed an increase in MPV and a decrease in PLT count in non-surviving patients compared with surviving patients [@b47-cln_70p61]. In the IR group, we found an increase in the PLT count and a decrease in the MPV value, in contrast to this previous study. This discrepancy could be attributed to different occlusion models because AMI patients can present partial vascular occlusions that last for less-precise amounts of time. In addition, we cannot correlate this change with mortality rate, as the model involving 45 min of intestinal ischemia in rats has been considered to be free of mortality [@b48-cln_70p61], whereas the ischemic period and severity varies among clinical conditions, leading to higher morbidity and mortality. For example, AMI has an overall mortality of 60% to 80% and the reported incidence increases over time [@b49-cln_70p61],[@b50-cln_70p61], mostly because of the continued difficulty in recognizing this condition [@b50-cln_70p61]. The effect of IPC on these parameters with AMI requires further validation in humans.

In summary, our results demonstrate that IPC before intestinal IR provoked significant alterations in hematimetric parameters in the IPC group compared with that in the IR group, mainly comprising decreases in the granulocyte count and PCT count and increases in the lymphocyte count and the MPV.

The results of the present study indicate that 10 min of IPC before 45 min of intestinal IR alter the hematimetric parameters, suggesting that IPC attenuates the effect of IR in circulating blood cells.
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Hematological analyses, expressed as the mean±standard deviation, median and range (min. - max.) of the four groups.

  Parameters                   Control group   Laparotomy group   Ischemia/Reperfusion group   Preconditioning group                                                                                    
  ---------------------------- --------------- ------------------ ---------------------------- ----------------------- ------- ------------ -------------- ------- ------------ -------------- -------- -------------
  **WBC (10^9^/L)**            10.27±2.04      10.85              6.8-12.3                     14.71±3.4               15.75   8.6-18.7     18.13±5.16     19.1    11.8-15.75   16.39±4.67     15.7     8.7-23.2
  **Lymphocytes (10^9^/L)**    6.79±1.59       7.2                4.1-8.8                      5.6±1.42                5.3     3.5-7.7      5.65±1.28      5.65    3.7-8.8      5.61±2.24      5.05     3.9-11.6
  **Monocytes (10^9^/L)**      0.31±0.07       0.3                0.2-0.4                      0.6±0.28                0.5     0.3-1.2      0.71±0.29      0.6     0.4-0.6      0.57±0.19      0.6      0.3-0.8
  **Granulocytes (10^9^/L)**   3.17±0.59       3.1                2.3-3.9                      8.51±2.11               9.15    4.7-10.7     13.36±6.31     12.85   5-9.15       10.21±3.7      9.85     4.5-17.6
  **Lymphocytes (%)**          64.76±2.96      65.1               60-70.8                      38.26±4.98              39.95   30.3-45.1    28.47±5.23     27.35   22-70.8      36.33±8.19     34.85    26.7-51.8
  **Monocytes (%)**            3.25±0.36       3.1                2.9-3.9                      3.68±0.6                3.6     2.9-4.7      3.36±0.28      3.35    3-3.9        3.81±0.43      3.85     3.2-4.7
  **Granulocytes (%)**         32.1±2.86       31.65              26.2-37.1                    57.63±4.61              56.75   51.1-65.9    67.87±5.74     69.5    57.5-57.63   59.89±8.25     61.45    44.5-69.3
  **RBC (10^12^/L)**           6.528±0.55      6.58               5.49-7.52                    7.38±0.72               7.65    6.1-8.3      7.66±0.52      7.665   6.88-7.65    7.32±1.38      7.63     4.62-9.58
  **Hb (g/L)**                 128±6.94        126.5              120-142                      138.5±12.03             138.5   120-156      143.3±7.69     144     134-142      141±20.02      147.5    107-167
  **HCT (%)**                  40.83±1.86      40.45              38.8-44.4                    44.63±3.63              44.95   38.7-49.8    47.07±2.61     46.85   43.3-44.95   45.14±6.31     47.65    34.2-54.2
  **MCV (fL)**                 61.39±2.46      61.1               57.2-65.1                    60.41±1.95              59.95   58-63.7      61.57±2.34     61.2    58.2-65.1    60.8±2.39      60.75    56.6-64.7
  **MCH**                      19.16±0.75      19.15              17.6-20.3                    18.6±0.67               18.6    17.8-19.7    18.7±0.8       18.8    17.5-20.3    18.98±0.73     19.05    17.4-20.1
  **MCHC (g/L)**               312.8±4.61      312.5              307-320                      308.7±5.89              308.5   301-320      304.1±5.36     302.5   297-320      312.7±7.12     313.5    303-325
  **RDW (%)**                  11.46±0.72      11.2               10.7-12.7                    11.96±0.65              11.95   10.5-12.9    12.52±1.35     12.15   11-12.7      12.87±1.32     12.7     11.5-15.2
  **PLT (10^9^/L)**            746.6±148.32    785.5              529-943                      837.3±92.71             828     679-1024     867.2±154.25   800.5   734-943      653.1±248.34   665      341-1135
  **MPV (fL)**                 5.3±0.2         5.3                5-5.7                        5.45±0.18               5.45    5.1-5.8      5.64±0.2       5.6     5.4-5.7      5.93±0.33      5.95     5.5-6.4
  **PDW**                      16.1±0.24       16.05              15.8-16.5                    16.15±0.26              16.15   15.8-16.7    16.13±0.13     16.15   15.9-16.5    16.86±0.68     16.9     15.9-18.1
  **PCT (%)**                  0.3946±0.08     0.412              0.275-0.49                   0.46±0.03               0.456   0.418-0.52   0.49±0.09      0.441   0.401-0.49   0.3763±0.12    0.3945   0.218-0.578
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